National Translational Research Group

East Setauket, New York 11733

0 studies enrolling now · 2 studies all time

What they study most

Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumor

Studies at this site

• Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer — Stopped early
• Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) — Completed